Yahoo · Sep 28, 2026
Novavax (NVAX) Rises As Market Takes a Dip: Key Facts
In the closing of the recent trading day, Novavax (NVAX) stood at $10.79, denoting a +1.53% move from the preceding trading day.
NV
NASDAQ · NVAX
Novavax, Inc.
Healthcare · Biotechnology
$12.56
Down-$1.60 (-12.74%)
Updated Oct 6, 2026, 6:15 PM
SID Score
5.1/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.09B
- P/E ratio
- 3.18
- Dividend yield
- 0.00%
- 52-week range
- $7.15 – $13.39
- Volume
- 28.7M
- Avg. volume
- 4.26M
Price performance · NVAX
NVAX price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 5, 2026
NVAX closed at $12.56 after 20 trading sessions, up 23.26% for the selected period.
- Last close
- $12.56
- Period change
- +23.26%
- Period low
- $9.23
- Period high
- $12.56
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 5, 2026 | $10.47 | $13.385 | $10.275 | $12.56 | 28.7M |
| Oct 2, 2026 | $10.80 | $10.86 | $10.33 | $10.46 | 4.03M |
| Oct 1, 2026 | $10.75 | $10.98 | $10.545 | $10.60 | 3.15M |
| Sep 30, 2026 | $10.85 | $11.095 | $10.54 | $10.81 | 4.57M |
| Sep 29, 2026 | $10.80 | $11.1099 | $10.41 | $10.82 | 4.07M |
| Sep 28, 2026 | $10.495 | $10.975 | $10.26 | $10.80 | 4.46M |
| Sep 25, 2026 | $10.62 | $10.79 | $10.335 | $10.63 | 3.91M |
| Sep 24, 2026 | $10.425 | $10.85 | $10.38 | $10.60 | 4.35M |
| Sep 23, 2026 | $10.79 | $10.945 | $10.465 | $10.55 | 5.77M |
| Sep 22, 2026 | $10.39 | $11.09 | $10.15 | $10.83 | 7.58M |
| Sep 21, 2026 | $10.38 | $10.70 | $10.21 | $10.41 | 6.14M |
| Sep 18, 2026 | $9.89 | $10.145 | $9.76 | $10.11 | 11.15M |
| Sep 17, 2026 | $9.615 | $10.38 | $9.61 | $10.00 | 8.88M |
| Sep 16, 2026 | $9.35 | $9.41 | $9.155 | $9.35 | 2.85M |
| Sep 15, 2026 | $9.50 | $9.56 | $9.16 | $9.23 | 3.33M |
| Sep 14, 2026 | $9.38 | $9.60 | $9.135 | $9.59 | 3.37M |
| Sep 11, 2026 | $9.29 | $9.865 | $9.23 | $9.42 | 6.12M |
| Sep 10, 2026 | $9.64 | $9.68 | $9.11 | $9.30 | 5.89M |
| Sep 9, 2026 | $10.02 | $10.242 | $9.73 | $9.85 | 4.44M |
| Sep 8, 2026 | $10.099 | $10.3599 | $9.75 | $10.19 | 4.23M |
Latest NVAX news
The latest Smart Investors Daily articles mentioning NVAX.
Stock researchCompany · Overview
Company
Market Activity
Research & News
NVAX research
Overview
Company profile and research snapshot.
Company profile
Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- $14.50
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 11, 2026 | BTIG | Buy | — |
| May 6, 2026 | TD Cowen | Hold | — |
| Feb 27, 2026 | HC Wainwright & Co. | Buy | — |
| Jan 20, 2026 | BTIG | Buy | — |
| Nov 18, 2025 | JP Morgan | Underweight | — |
News briefing
No generated briefing is available yet.
Yahoo · Sep 28, 2026
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Novavax (NVAX). This makes it worthwhile to examine what the stock has in store.
Yahoo · Sep 21, 2026
3 Volatile Stocks with Questionable Fundamentals
Volatility cuts both ways - while it creates opportunities, it also increases risk, making sharp declines just as likely as big gains. This unpredictability can shake out even the most experienced investors.
Yahoo · Sep 18, 2026
Novavax (NVAX) Beats Stock Market Upswing: What Investors Need to Know
In the most recent trading session, Novavax (NVAX) closed at $10.11, indicating a +1.1% shift from the previous trading day.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
